This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
The Alu-insertion progesterone receptor gene polymorphism is not associated with breast cancer: a meta-analysis
BMC Medical Genetics Open Access 25 January 2018
-
Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the ovarian cancer association consortium pooled analysis
British Journal of Cancer Open Access 22 January 2008
-
A novel duplication polymorphism in the FANCApromoter and its association with breast and ovarian cancer
BMC Cancer Open Access 29 April 2005
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
Manolitsas, T., Englefield, P., Eccles, D. et al. No association of a 306-bp insertion polymorphism in the progesterone receptor gene with ovarian and breast cancer. Br J Cancer 75, 1398–1399 (1997). https://doi.org/10.1038/bjc.1997.238
Issue Date:
DOI: https://doi.org/10.1038/bjc.1997.238
This article is cited by
-
Autophagy-mediating microRNAs in cancer chemoresistance
Cell Biology and Toxicology (2020)
-
The Alu-insertion progesterone receptor gene polymorphism is not associated with breast cancer: a meta-analysis
BMC Medical Genetics (2018)
-
Progesterone receptor PROGINS and +331G/A polymorphisms confer susceptibility to ovarian cancer: a meta-analysis based on 17 studies
Tumor Biology (2014)
-
Analyze association of the progesterone receptor gene polymorphism PROGINS with ovarian cancer risk
Molecular Biology Reports (2013)
-
Hormone receptor-related gene polymorphisms and prostate cancer risk in North Indian population
Molecular and Cellular Biochemistry (2008)